GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Pulsion Medical Systems SE (LTS:0NFX) » Definitions » Gross Profit

Pulsion Medical Systems SE (LTS:0NFX) Gross Profit : €12.40 Mil (TTM As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Pulsion Medical Systems SE Gross Profit?

Pulsion Medical Systems SE's gross profit for the six months ended in Dec. 2023 was €12.40 Mil. Pulsion Medical Systems SE's gross profit for the trailing twelve months (TTM) ended in Dec. 2023 was €12.40 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Pulsion Medical Systems SE's gross profit for the six months ended in Dec. 2023 was €12.40 Mil. Pulsion Medical Systems SE's Revenue for the six months ended in Dec. 2023 was €35.80 Mil. Therefore, Pulsion Medical Systems SE's Gross Margin % for the quarter that ended in Dec. 2023 was 34.64%.

Pulsion Medical Systems SE had a gross margin of 34.64% for the quarter that ended in Dec. 2023 => Competition eroding margins

During the past 13 years, the highest Gross Margin % of Pulsion Medical Systems SE was 63.66%. The lowest was 34.64%. And the median was 57.57%.

Warning Sign:

Pulsion Medical Systems SE gross margin has been in long-term decline. The average rate of decline per year is -8.5%.


Pulsion Medical Systems SE Gross Profit Historical Data

The historical data trend for Pulsion Medical Systems SE's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pulsion Medical Systems SE Gross Profit Chart

Pulsion Medical Systems SE Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.68 18.95 14.83 15.28 12.40

Pulsion Medical Systems SE Semi-Annual Data
Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.68 18.95 14.83 15.28 12.40

Competitive Comparison of Pulsion Medical Systems SE's Gross Profit

For the Medical Devices subindustry, Pulsion Medical Systems SE's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pulsion Medical Systems SE's Gross Profit Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Pulsion Medical Systems SE's Gross Profit distribution charts can be found below:

* The bar in red indicates where Pulsion Medical Systems SE's Gross Profit falls into.



Pulsion Medical Systems SE Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Pulsion Medical Systems SE's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )=Revenue - Cost of Goods Sold
=35.795 - 23.394
=12.40

Pulsion Medical Systems SE's Gross Profit for the quarter that ended in Dec. 2023 is calculated as

Gross Profit (Q: Dec. 2023 )=Revenue - Cost of Goods Sold
=35.795 - 23.394
=12.40

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Gross Profit for the trailing twelve months (TTM) ended in Dec. 2023 was €12.40 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Pulsion Medical Systems SE's Gross Margin % for the quarter that ended in Dec. 2023 is calculated as

Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=(Revenue - Cost of Goods Sold) / Revenue
=12.40 / 35.795
=34.64 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Pulsion Medical Systems SE  (LTS:0NFX) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Pulsion Medical Systems SE had a gross margin of 34.64% for the quarter that ended in Dec. 2023 => Competition eroding margins


Pulsion Medical Systems SE Gross Profit Related Terms

Thank you for viewing the detailed overview of Pulsion Medical Systems SE's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Pulsion Medical Systems SE (LTS:0NFX) Business Description

Traded in Other Exchanges
N/A
Address
Hans-Riedl-Street 17, Feldkirchen, DEU, 85622
Pulsion Medical Systems SE operates with its business units hemodynamic monitoring which is engaged in developing, manufacturing, and sale of systems used to monitor, diagnose, and manage physical parameters of patients in intensive care unit, and perfusion imaging which is engaged in developing, manufacturing, and sale of indocyanine green and complementary devices to visualize micro perfusion. The technology developed by the company for critical care are picco, proaqt, limon technology, and eirus technology.

Pulsion Medical Systems SE (LTS:0NFX) Headlines

No Headlines